The Dublin, Ohio-based company is the latest to join the trend of healthcare service companies diversifying beyond drug ...

Yardley, the associate director of breast cancer research at the Sarah Cannon Research Institute in Nashville, was one of the clinical trial investigators. Patients in the trial either took the ...

In the complex landscape of cancer, tumors create their own microenvironment, often marked by low oxygen levels, a condition ...

New study shows that AI can predict lung cancer from digitized patient tissue samples rapidly and with a high degree of ...

BioMed X, a German biomedical research institute, announced the start of a new research ... we aim to develop a wider range of effective therapies for cancer patients” explains Dr. Stefanie Bärthel, ...

The Joint Center of Excellence for Point of Care Precision Medicine aims to develop better personalized care for patients ...

LA-based Portl launched a 7-ft-tall hologram projection box for life-like remote communications. Now renamed Proto, the ...

LifeSci Capital analyst Sam Slutsky maintained a Buy rating on CG Oncology, Inc. (CGON – Research Report) today and set a price target of $86.00. Sam Slutsky has given his Buy rating due to a ...

The FDA expanded approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease. The decision will free up access to the medication for tens of ...

New research shows about one in eight of all cancer cases are linked to common infections like HPV, Hepatitis B and C and H. pylori. NBC News medical contributor Dr. Natalie Azar joins TODAY to ...

Relay Therapeutics has demonstrated resilience in the face of competition at the European Society for Medical Oncology (ESMO) meeting, particularly with its PI3K inhibitors for advanced breast cancer.

How does a proto-oncogene cause cancer? In the early twentieth century, a tumor-causing virus called the Rous sarcoma virus (retrovirus) was discovered. 3 Host cell proto-oncogene (c-src ...